- Goyovy přízraky2007 | Filozofická fakulta
- Manet : Umělec a člověk2018 | Pedagogická fakulta
- Právněhistorické aspekty filmu Goyovy přízraky a španělská inkvizice2014 | Právnická fakulta
- End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA2021 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA2020 | 1. lékařská fakulta
- A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYA2022 | 1. lékařská fakulta
- Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study2022 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study2020 | 1. lékařská fakulta
- A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA2020 | 1. lékařská fakulta
- Zpovídat se z cizích hříchů2022 | Pedagogická fakulta
- BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis2021 | 1. lékařská fakulta
- Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment2021 | 1. lékařská fakulta
- Single-nucleotide Fc gamma receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma2021 | 1. lékařská fakulta
- Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma2017 | Publikace bez příslušnosti k fakultě
- Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy2019 | 1. lékařská fakulta
- A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma2021 | 1. lékařská fakulta
- Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL2019 | 1. lékařská fakulta